(Q43268257)

17 November 2017

title

Environmental and genetic factors influence the relationship between circulating IL-10 and obesity phenotypes (English)

1 reference

José María Moreno-Navarrete

17 November 2017

0 references

3

1 reference

17 November 2017

Elías Delgado Álvarez

4

1 reference

17 November 2017

Francisco Jose Ortega

5

1 reference

17 November 2017

6

1 reference

José Manuel Fernández-Real

17 November 2017

7

1 reference

17 November 2017

Judit Bassols

1

0 references

Patrícia Bota

2

object named as

Patricia Botas

1 reference

17 November 2017

publication date

1 October 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

18

1 reference

17 November 2017

issue

3

1 reference

17 November 2017

page(s)

611-618

1 reference

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Insulin resistance and chronic cardiovascular inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Association of low interleukin-10 levels with the metabolic syndrome in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Haplotype associated with low interleukin-10 production in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Association of adenovirus infection with human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

A human adenovirus enhances preadipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Burden of infection and fat mass in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Burden of infection and insulin resistance in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Genetic variations in humans associated with differences in the course of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Resolution of a chronic viral infection after interleukin-10 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

IL-10 and the resolution of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Soluble TNF-α receptor 2 produced by alternative splicing is paradoxically associated with markers of liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Inflammation and stroke: the Leiden 85-Plus Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.313

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2009.313

1 reference

17 November 2017

1 reference